Symbols / OM Stock $4.38 +13.47% Outset Medical, Inc.

Healthcare • Medical Devices • United States • NMS
OM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Ms. Leslie L. Trigg
Exch · Country NMS · United States
Market Cap 81.19M
Enterprise Value 16.46M
Income -74.85M
Sales 117.59M
FCF (ttm) -10.46M
Book/sh 6.99
Cash/sh 8.45
Employees 310
Insider 10d —
IPO Sep 15, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -2.01
PEG —
P/S 0.69
P/B 0.63
P/C —
EV/EBITDA -0.26
EV/Sales 0.14
Quick Ratio 4.84
Current Ratio 6.29
Debt/Eq 90.98
LT Debt/Eq —
EPS (ttm) -2.74
EPS next Y -2.18
EPS Growth —
Revenue Growth -6.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-07
ROA -15.26%
ROE -53.17%
ROIC —
Gross Margin 40.64%
Oper. Margin -60.72%
Profit Margin -63.65%
Shs Outstand 18.54M
Shs Float 15.91M
Insider Own 3.62%
Instit Own 80.81%
Short Float 14.75%
Short Ratio 16.73
Short Interest 2.01M
52W High 21.98
vs 52W High -80.07%
52W Low 3.00
vs 52W Low 46.00%
Beta 1.91
Impl. Vol. 2.06%
Rel Volume 1.39
Avg Volume 177.67K
Volume 247.20K
Target (mean) $8.33
Tgt Median $8.00
Tgt Low $7.00
Tgt High $10.00
# Analysts 3
Recom Buy
Prev Close $3.86
Price $4.38
Change 13.47%
About

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.33
Mean price target
2. Current target
$4.38
Latest analyst target
3. DCF / Fair value
$-10.15
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.38
Low
$7.00
High
$10.00
Mean
$8.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-12 main BTIG Buy → Buy $15
2026-01-07 main Stifel Buy → Buy $8
2025-12-16 reit BTIG Buy → Buy $17
2025-11-11 main Stifel Buy → Buy $14
2025-11-11 main RBC Capital Sector Perform → Sector Perform $17
2025-11-11 main BTIG Buy → Buy $17
2025-08-19 reit RBC Capital Sector Perform → Sector Perform $22
2025-08-07 main RBC Capital Sector Perform → Sector Perform $22
2025-05-21 main RBC Capital Sector Perform → Sector Perform $21
2025-05-08 main RBC Capital Sector Perform → Sector Perform $14
2025-01-07 reit RBC Capital Sector Perform → Sector Perform $3
2024-08-08 down RBC Capital Outperform → Sector Perform $3
2024-08-08 main TD Cowen Buy → Buy $3
2024-06-21 up RBC Capital Sector Perform → Outperform $6
2024-04-08 init BTIG — → Buy $6
2024-01-12 down RBC Capital Outperform → Sector Perform $6
2023-12-04 main Morgan Stanley Equal-Weight → Equal-Weight $6
2023-11-14 main Morgan Stanley Equal-Weight → Equal-Weight $5
2023-10-13 main RBC Capital Outperform → Outperform $17
2023-10-13 main Stifel Buy → Buy $6
News
RSS: Latest OM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-15 LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security — 323,000 $5.00 $1,615,000
2026-05-11 LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security — 294,500 $5.00 $1,472,500
2026-04-06 ELLIOTT DERICK A Officer — 96,000 $0.00 $0
2026-02-17 TRIGG LESLIE L Chief Executive Officer — 3,361 $3.35 $11,259
2026-02-17 BROTTEM JOHN L. General Counsel — 2,842 $3.35 $9,521
2026-02-17 NASH MARC Officer — 1,817 $3.35 $6,087
2026-01-21 TRIGG LESLIE L Chief Executive Officer — 13,914 $5.05 $71,091
2026-01-21 BROTTEM JOHN L. General Counsel — 10,494 $5.01 $53,599
2026-01-21 NASH MARC Officer — 6,355 $4.98 $32,400
2026-01-09 PRANGE KAREN N. Director — 18,667 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
119.48
+5.09%
113.69
-12.80%
130.38
+13.00%
115.38
Operating Revenue
119.48
+5.09%
113.69
-12.80%
130.38
+13.00%
115.38
Cost Of Revenue
72.72
-3.20%
75.12
-25.89%
101.38
+3.93%
97.54
Reconciled Cost Of Revenue
72.72
-3.20%
75.12
-25.89%
101.38
+3.93%
97.54
Gross Profit
46.75
+21.24%
38.56
+32.98%
29.00
+62.62%
17.83
Operating Expense
113.46
-25.33%
151.94
-23.56%
198.77
+11.14%
178.85
Research And Development
21.23
-44.70%
38.40
-33.00%
57.31
+17.30%
48.85
Selling General And Administration
92.22
-18.77%
113.54
-19.74%
141.46
+8.82%
130.00
Selling And Marketing Expense
54.36
-22.39%
70.04
-27.21%
96.23
+7.54%
89.48
General And Administrative Expense
37.86
-12.95%
43.50
-3.83%
45.23
+11.64%
40.52
Other Gand A
37.86
-12.95%
43.50
-3.83%
45.23
+11.64%
40.52
Total Expenses
186.18
-18.00%
227.06
-24.35%
300.15
+8.59%
276.39
Operating Income
-66.71
+41.16%
-113.38
+33.22%
-169.77
-5.43%
-161.02
Total Operating Income As Reported
-66.71
+41.16%
-113.38
+33.22%
-169.77
-5.43%
-161.02
EBITDA
-62.64
+36.01%
-97.89
+36.35%
-153.79
+0.09%
-153.93
Normalized EBITDA
-54.96
+43.86%
-97.89
+36.35%
-153.79
-0.81%
-152.56
Reconciled Depreciation
4.34
-24.21%
5.73
-1.41%
5.81
+12.40%
5.17
EBIT
-66.98
+35.35%
-103.61
+35.08%
-159.60
-0.32%
-159.09
Total Unusual Items
-7.68
0.00
0.00
+100.00%
-1.37
Total Unusual Items Excluding Goodwill
-7.68
0.00
0.00
+100.00%
-1.37
Special Income Charges
-7.68
0.00
0.00
+100.00%
-1.37
Other Special Charges
7.68
—
—
1.37
Net Income
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Pretax Income
-80.94
+36.51%
-127.48
+26.00%
-172.27
-5.91%
-162.66
Net Non Operating Interest Income Expense
-6.54
+53.62%
-14.11
-463.50%
-2.50
-810.55%
-0.28
Interest Expense Non Operating
13.95
-41.55%
23.87
+88.33%
12.68
+255.44%
3.57
Net Interest Income
-6.54
+53.62%
-14.11
-463.50%
-2.50
-810.55%
-0.28
Interest Expense
13.95
-41.55%
23.87
+88.33%
12.68
+255.44%
3.57
Interest Income Non Operating
7.41
-24.11%
9.76
-4.03%
10.17
+209.05%
3.29
Interest Income
7.41
-24.11%
9.76
-4.03%
10.17
+209.05%
3.29
Other Income Expense
-7.68
—
—
-1.37
Tax Provision
0.72
+46.23%
0.49
-6.12%
0.52
+77.29%
0.29
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.61
0.00
0.00
+100.00%
-0.29
Net Income Including Noncontrolling Interests
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Net Income From Continuing Operation Net Minority Interest
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Net Income From Continuing And Discontinued Operation
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Net Income Continuous Operations
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Normalized Income
-75.58
+40.94%
-127.98
+25.94%
-172.80
-6.75%
-161.88
Net Income Common Stockholders
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-5.37
+85.45%
-36.90
+29.31%
-52.20
-2.96%
-50.70
Basic EPS
-5.37
+85.45%
-36.90
+29.31%
-52.20
-2.96%
-50.70
Basic Average Shares
15.21
+339.19%
3.46
+4.77%
3.31
+2.96%
3.21
Diluted Average Shares
15.21
+339.19%
3.46
+4.77%
3.31
+2.96%
3.21
Diluted NI Availto Com Stockholders
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Line Item Trend 2023-12-31
Total Assets
313.80
Current Assets
291.22
Cash Cash Equivalents And Short Term Investments
203.32
Cash And Cash Equivalents
68.51
Other Short Term Investments
134.81
Receivables
32.98
Accounts Receivable
32.98
Inventory
49.22
Raw Materials
18.71
Work In Process
8.73
Finished Goods
21.78
Prepaid Assets
—
Other Current Assets
5.70
Total Non Current Assets
22.58
Net PPE
18.65
Gross PPE
35.02
Accumulated Depreciation
-16.37
Properties
0.00
Machinery Furniture Equipment
18.73
Construction In Progress
0.77
Other Properties
5.90
Leases
9.62
Other Non Current Assets
3.93
Total Liabilities Net Minority Interest
190.91
Current Liabilities
55.32
Payables And Accrued Expenses
17.24
Payables
5.83
Accounts Payable
5.83
Current Accrued Expenses
11.41
Pensionand Other Post Retirement Benefit Plans Current
19.00
Current Debt And Capital Lease Obligation
1.59
Current Capital Lease Obligation
1.59
Current Deferred Liabilities
11.73
Current Deferred Revenue
11.73
Other Current Liabilities
5.76
Total Non Current Liabilities Net Minority Interest
135.59
Long Term Debt And Capital Lease Obligation
134.59
Long Term Debt
130.11
Long Term Capital Lease Obligation
4.48
Non Current Deferred Liabilities
0.10
Non Current Deferred Revenue
0.10
Stockholders Equity
122.89
Common Stock Equity
122.89
Capital Stock
0.05
Common Stock
0.05
Preferred Stock
0.00
Share Issued
3.35
Ordinary Shares Number
3.35
Treasury Shares Number
0.00
Additional Paid In Capital
1,084.52
Retained Earnings
-961.75
Gains Losses Not Affecting Retained Earnings
0.07
Other Equity Adjustments
0.07
Total Equity Gross Minority Interest
122.89
Total Capitalization
253.00
Working Capital
235.90
Invested Capital
253.00
Total Debt
136.19
Net Debt
61.60
Capital Lease Obligations
6.08
Net Tangible Assets
122.89
Tangible Book Value
122.89
Current Provisions
—
Non Current Accrued Expenses
0.90
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-46.33
+60.17%
-116.30
+11.47%
-131.37
+9.85%
-145.73
Cash Flow From Continuing Operating Activities
-46.33
+60.17%
-116.30
+11.47%
-131.37
+9.85%
-145.73
Net Income From Continuing Operations
-81.65
+36.20%
-127.98
+25.94%
-172.80
-6.04%
-162.96
Depreciation Amortization Depletion
4.34
-24.21%
5.73
-1.41%
5.81
+12.40%
5.17
Depreciation
—
—
—
—
Depreciation And Amortization
4.34
-24.21%
5.73
-1.41%
5.81
+12.40%
5.17
Other Non Cash Items
4.34
+8.28%
4.01
+29.36%
3.10
+107.29%
1.50
Stock Based Compensation
15.62
-46.80%
29.36
-24.02%
38.63
+42.02%
27.20
Provisionand Write Offof Assets
3.39
+15.54%
2.94
+220.07%
0.92
-65.36%
2.65
Operating Gains Losses
7.69
+14409.43%
0.05
-50.00%
0.11
-92.46%
1.41
Gain Loss On Sale Of PPE
0.01
-90.57%
0.05
-50.00%
0.11
+171.79%
0.04
Change In Working Capital
2.20
+108.56%
-25.69
-3223.16%
-0.77
+96.34%
-21.14
Change In Receivables
3.77
+175.32%
-5.01
+1.61%
-5.09
-103.27%
-2.51
Changes In Account Receivables
3.77
+175.32%
-5.01
+1.61%
-5.09
-103.27%
-2.51
Change In Inventory
11.79
+208.62%
-10.86
-759.20%
1.65
+111.18%
-14.73
Change In Prepaid Assets
-0.94
-219.90%
0.78
+6.09%
0.74
+160.82%
-1.22
Change In Payables And Accrued Expense
-11.12
-3.15%
-10.78
-4137.08%
0.27
+107.21%
-3.70
Change In Accrued Expense
-7.83
+11.38%
-8.83
-75.04%
-5.04
-108.38%
-2.42
Change In Payable
-3.29
-69.05%
-1.95
-136.67%
5.31
+514.68%
-1.28
Change In Account Payable
-3.29
-69.05%
-1.95
-136.67%
5.31
+514.68%
-1.28
Change In Other Working Capital
0.60
-65.86%
1.77
-41.33%
3.02
+39.52%
2.16
Change In Other Current Liabilities
-1.91
-20.09%
-1.59
-18.26%
-1.35
-17.13%
-1.15
Investing Cash Flow
-97.68
-193.98%
103.94
+25.19%
83.03
+225.24%
-66.30
Cash Flow From Continuing Investing Activities
-97.68
-193.98%
103.94
+25.19%
83.03
+225.24%
-66.30
Net PPE Purchase And Sale
-0.80
+12.50%
-0.91
+73.49%
-3.44
+58.68%
-8.32
Purchase Of PPE
-0.80
+12.50%
-0.91
+73.49%
-3.44
+58.68%
-8.32
Capital Expenditure
-0.80
+12.50%
-0.91
+73.49%
-3.44
+58.68%
-8.32
Net Investment Purchase And Sale
-96.89
-192.40%
104.85
+21.26%
86.47
+249.16%
-57.97
Purchase Of Investment
-221.97
-41.76%
-156.58
+9.11%
-172.28
+34.03%
-261.15
Sale Of Investment
125.08
-52.16%
261.43
+1.04%
258.75
+27.35%
203.18
Financing Cash Flow
55.50
-18.22%
67.87
+55.48%
43.65
-40.12%
72.90
Cash Flow From Continuing Financing Activities
55.50
-18.22%
67.87
+55.48%
43.65
-40.12%
72.90
Net Issuance Payments Of Debt
-106.68
-260.37%
66.52
+100.22%
33.23
-48.77%
64.86
Issuance Of Debt
98.27
+47.72%
66.52
+100.22%
33.23
-65.41%
96.06
Repayment Of Debt
-204.95
0.00
0.00
+100.00%
-31.20
Long Term Debt Issuance
98.27
+47.72%
66.52
+100.22%
33.23
-65.41%
96.06
Long Term Debt Payments
-204.95
0.00
0.00
+100.00%
-31.20
Net Long Term Debt Issuance
-106.68
-260.37%
66.52
+100.22%
33.23
-48.77%
64.86
Net Common Stock Issuance
—
—
0.00
0.00
Proceeds From Stock Option Exercised
0.64
-72.02%
2.28
-78.10%
10.43
+29.66%
8.04
Net Other Financing Charges
—
-0.94
—
—
Changes In Cash
-88.51
-259.46%
55.51
+1282.22%
-4.70
+96.63%
-139.13
Beginning Cash Position
127.34
+77.26%
71.84
-6.13%
76.53
-64.51%
215.66
End Cash Position
38.84
-69.50%
127.34
+77.26%
71.84
-6.13%
76.53
Free Cash Flow
-47.12
+59.80%
-117.22
+13.05%
-134.81
+12.49%
-154.05
Interest Paid Supplemental Data
15.63
-24.42%
20.68
+90.70%
10.85
+240.57%
3.19
Income Tax Paid Supplemental Data
0.45
-24.62%
0.59
+20.77%
0.49
+27.53%
0.39
Amortization Of Securities
-2.25
+52.27%
-4.72
+25.89%
-6.37
-1518.49%
0.45
Change In Interest Payable
-2.69
0.00
0.00
+100.00%
-0.72
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
161.55
0.00
0.00
0.00
Net Preferred Stock Issuance
161.55
0.00
0.00
0.00
Preferred Stock Issuance
161.55
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category